Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006-Reference-Cited by-同舟云学术

Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006

Published:2013-11-22 Issue:3 Volume:53 Page:502-511
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Strand V.,Petri M.,Kalunian K.,Gordon C.,Wallace D. J.,Hobbs K.,Kelley L.,Kilgallen B.,Wegener W. A.,Goldenberg D. M.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/53/3/502/5043191/ket378.pdf

Reference35 articles.

1. Systemic Lupus Erythematosus

2. Why can't we find a new treatment for SLE?

3. Systemic Lupus Erythematosus

4. Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus

5. Measuring outcomes in systemic lupus erythematosus clinical trials

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical advances in immunotherapy for immune-mediated glomerular diseases;Clinical and Experimental Medicine;2023-10-27

2. Advances in natural products and antibody drugs for SLE: new therapeutic ideas;Frontiers in Pharmacology;2023-07-10

3. Do biological agents improve health-related quality of life in patients with systemic lupus erythematosus? Results from a systematic search of the literature;Autoimmunity Reviews;2022-11

4. Clinical trials in systemic lupus erythematosus: the dilemma—Why have phase III trials failed to confirm the promising results of phase II trials?;Annals of the Rheumatic Diseases;2022-10-06

5. SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases;The Journal of Immunology;2022-06-15